Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JAK inhibitors
JAK inhibitors
Baxalta drops, CTI nosedives after patient deaths & adverse events prompt FDA partial hold
BioPharma Dive
Mon, 02/8/16 - 10:24 am
Baxalta
Shire
CTI BioPharma
pacritinib
JAK inhibitors
How Big a Threat is Eli Lilly to Gilead Sciences?
Bidness, ETC
Wed, 01/20/16 - 08:40 am
Eli Lilly
Gilead Sciences
baricitinib
JAK inhibitors
Incyte and AstraZeneca Announce New Lung Cancer Clinical Trial Collaboration
Yahoo
Mon, 01/11/16 - 08:34 am
Incyte
AstraZeneca
lung cancer
clinical trials
INCB39110
JAK inhibitors
AbbVie Announces the Launch of Robust Phase 3 Clinical Trial Program Evaluating ABT-494, an Investigational Selective JAK1 Inhibitor, for the Treatment of Rheumatoid Arthritis
Yahoo
Fri, 01/8/16 - 09:49 am
AbbVie
rheumatoid arthritis
JAK inhibitors
ABT-494
Can Gilead Sciences Save Key Pipeline Blockbusters from Rivals?
Bidness, ETC
Sat, 01/2/16 - 10:16 am
Gilead Sciences
simtuzumab
NASH
JAK inhibitors
filgotinib
Gilead joins Pfizer and Eli Lilly in JAK Race
Bidness, ETC
Sun, 12/27/15 - 10:24 am
Gilead Sciences
JAK inhibitors
Pfizer
Eli Lilly
filgotinib
Galapagos
Xeljanz
baricitinib
AbbVie dumps Galapagos' arthritis drug and presses on with its own
Fierce Biotech
Fri, 09/25/15 - 10:13 am
AbbVie
Galapagos
rheumatoid arthritis
ABT-494
JAK inhibitors
Galapagos starts timer on AbbVie buy-in decision with posting of final data
Fierce Biotech
Fri, 08/14/15 - 09:20 am
Galapagos
AbbVie
JAK inhibitors
rheumatoid arthritis
filgotinib
J&J scuttles a $945M arthritis deal with Astellas on the eve of Phase III
Fierce Biotech
Tue, 12/2/14 - 09:25 am
JNJ
Astellas
rheumatoid arthritis
ASP015K
JAK inhibitors
This Biotech Has So Many Reasons to Be Liked
Motley Fool
Fri, 09/6/13 - 09:12 am
Incyte
JAK inhibitors
Jakafi
myelofibrosis
Does Incyte Deserve Its New Valuation?
Motley Fool
Thu, 08/22/13 - 09:14 am
Incyte
JAK inhibitors
Jakafi
pancreatic cancer
AbbVie Ups Ante on JAK Inhibitor
Motley Fool
Sat, 06/1/13 - 12:21 pm
AbbVie
rheumatoid arthritis
JAK inhibitors
[video]AbbVie's New Crohn's Disease Drug Candidate
Motley Fool
Tue, 05/21/13 - 10:06 am
AbbVie
Crohn's Disease
JAK inhibitors
Galapagos
Can JAK Inhibitors Challenge Biologics?
Motley Fool
Wed, 02/20/13 - 05:15 pm
JAK inhibitors
Remicade
JNJ
Enbrel
Stelara
Amgen
Humira
AbbVie
Incyte Achieves $50 Million Milestone as Oral JAK1/JAK2 Inhibitor Baricitinib Advances into Phase III Development for Rheumatoid Arthritis
Yahoo
Thu, 11/15/12 - 11:06 am
baricitinib
Incyte
JAK inhibitors
Eli Lilly
rheumatoid arthritis
J&J and Astellas Collaborate
Yahoo/Zacks
Thu, 10/4/12 - 10:42 am
JNJ
Astellas
JAK inhibitors
ASP015K
rheumatoid arthritis
Pfizer's Success With Its JAK Inhibitor
Seeking Alpha
Fri, 08/17/12 - 10:18 am
Pfizer
JAK inhibitors
Abbott Laboratories
Amgen
Bristol-Myers Squibb
tofacitinib
rheumatoid arthritis
Will New RA Therapies Cause a Paradigm Shift?
Pharma Live
Tue, 08/14/12 - 02:25 pm
TNF blockers
rheumatoid arthritis
Humira
Abbott Laboratories
Pfizer
JAK inhibitors
tofacitinib
Amgen
Embrel
Remicade
JNJ
AstraZeneca Set To Gain From New Asthma Drug
Seeking Alpha
Thu, 06/28/12 - 10:31 am
asthma
AstraZeneca
Rigel
JAK inhibitors
Amgen
GSK
JNJ
Eli Lilly
Merck
R256
AstraZeneca, Rigel Pharmaceuticals sign license agreement for R256
Yahoo/Fly on the Wall
Tue, 06/19/12 - 10:13 am
Rigel Pharmaceuticals
AstraZeneca
R256
JAK inhibitors
Pages
« first
‹ previous
1
2
3
4
next ›
last »